Actively Recruiting
Effect of Point-of-care Analysis of Ultrasensitive Troponin I on Length of Hospital Stay in Patients With Cardiac Chest Pain (POC Troponina)
Led by University of Sao Paulo · Updated on 2025-04-08
200
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical study aims to compare two different methods for measuring high-sensitivity troponin I, a key biomarker used to diagnose heart attacks. The primary research question is: Does the use of the Atellica VTLi kit from Siemens for high-sensitivity troponin I (hs-cTnI) testing at the point of care (POC) significantly reduce the average time from admission to hospital discharge compared to the conventional laboratory methodology using the Alinity i kit from ABBOTT? Participant will: * Patients aged ≥ 18 years. * Patients arriving in the emergency room with symptoms suggestive of ACS, with onset of pain between 3 and 12 hours after arrival, in whom serial troponin dosing is planned for investigation. * Signature of the Informed Consent Form (ICF). Researchers will analyze whether the point-of-care testing method helps speed up the hospital discharge process compared to the standard laboratory approach. They will also compare the accuracy of the test results, the time taken for clinical decisions, and the overall cost-effectiveness of the two methods.
CONDITIONS
Official Title
Effect of Point-of-care Analysis of Ultrasensitive Troponin I on Length of Hospital Stay in Patients With Cardiac Chest Pain (POC Troponina)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged �3E= 18 years
- Patients arriving at the emergency room with symptoms suggestive of Acute Coronary Syndrome
- Onset of chest pain between 3 and 12 hours after arrival
- Planned serial troponin testing
- Signed informed consent form (ICF)
You will not qualify if you...
- Patients with Acute Coronary Syndrome with ST-segment elevation on ECG at arrival
- Patients with chronic renal failure, cancer, or chronic lung diseases that affect troponin interpretation
- Pregnant or breastfeeding patients
- Patients already enrolled in other clinical research studies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Instituto do Coração HCFMUSP
São Paulo, Brazil, 05403-000
Actively Recruiting
Research Team
J
José León
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here